
Michael Matson
Stock Analyst at Needham
(4.31)
# 1,406
Out of 5,189 analysts
1619
Total ratings
48.5%
Success rate
5.8%
Average return
Main Sectors:
Stocks Rated by Michael Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LIVN LivaNova | Reiterated: Buy | $93 → $112 | $90.73 | +23.44% | 88 | Nov 4, 2026 | |
| MMSI Merit Medical Systems | Reiterated: Buy | $101 → $106 | $84.34 | +25.68% | 71 | Oct 30, 2026 | |
| RMD ResMed | Reiterated: Hold | n/a | $235.63 | - | 97 | Oct 30, 2026 | |
| SYK Stryker | Reiterated: Buy | $418 → $359 | $310.00 | +15.81% | 76 | Oct 30, 2026 | |
| CNMD CONMED | Reiterated: Hold | n/a | $46.56 | - | 84 | Oct 29, 2026 | |
| NEO NeoGenomics | Reiterated: Buy | $22 | $14.82 | +48.45% | 41 | Oct 29, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $57 → $48 | $41.98 | +14.34% | 129 | Oct 28, 2026 | |
| HAE Haemonetics | Reiterated: Hold | n/a | $120.16 | - | 49 | Oct 21, 2026 | |
| ESTA Establishment Labs Holdings | Reiterated: Buy | $95 | $69.14 | +37.40% | 12 | Oct 15, 2026 | |
| ENOV Enovis | Reiterated: Buy | $52 → $34 | $25.47 | +33.49% | 20 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $5.30 | +126.42% | 88 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.3727 | +704.94% | 34 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $106 | $85.25 | +24.34% | 31 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $114 | $99.94 | +14.07% | 100 | Sep 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $69 | $25.13 | +174.57% | 37 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $64 | $55.39 | +15.54% | 104 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $159 → $170 | $161.58 | +5.21% | 72 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $1.97 | +356.85% | 37 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $58 | $45.55 | +27.33% | 1 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $18.16 | +142.29% | 61 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $165 → $187 | $172.52 | +8.39% | 14 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $14.27 | - | 40 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $255.76 | - | 34 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $12.42 | - | 42 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $35 | $31.74 | +10.27% | 52 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $101.10 | - | 89 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $319.12 | - | 24 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.02 | n/a | 2 | Apr 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 → $82 | $66.89 | n/a | 22 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $23.73 | n/a | 1 | Mar 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.05 | n/a | 50 | Dec 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.10 | n/a | 10 | Nov 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1 | $13.17 | n/a | 1 | Nov 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $636 | $399.05 | n/a | 1 | Apr 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $15 → $14 | $6.08 | n/a | 4 | Apr 9, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $6.07 | n/a | 1 | Apr 17, 2009 |
LivaNova
Nov 4, 2026
Reiterated: Buy
Price Target: $93 → $112
Current: $90.73
Upside: +23.44%
Merit Medical Systems
Oct 30, 2026
Reiterated: Buy
Price Target: $101 → $106
Current: $84.34
Upside: +25.68%
ResMed
Oct 30, 2026
Reiterated: Hold
Price Target: n/a
Current: $235.63
Upside: -
Stryker
Oct 30, 2026
Reiterated: Buy
Price Target: $418 → $359
Current: $310.00
Upside: +15.81%
CONMED
Oct 29, 2026
Reiterated: Hold
Price Target: n/a
Current: $46.56
Upside: -
NeoGenomics
Oct 29, 2026
Reiterated: Buy
Price Target: $22
Current: $14.82
Upside: +48.45%
Boston Scientific
Oct 28, 2026
Reiterated: Buy
Price Target: $57 → $48
Current: $41.98
Upside: +14.34%
Haemonetics
Oct 21, 2026
Reiterated: Hold
Price Target: n/a
Current: $120.16
Upside: -
Establishment Labs Holdings
Oct 15, 2026
Reiterated: Buy
Price Target: $95
Current: $69.14
Upside: +37.40%
Enovis
Oct 12, 2026
Reiterated: Buy
Price Target: $52 → $34
Current: $25.47
Upside: +33.49%
Oct 1, 2026
Reiterated: Buy
Price Target: $12
Current: $5.30
Upside: +126.42%
Oct 1, 2026
Reiterated: Buy
Price Target: $3
Current: $0.3727
Upside: +704.94%
Sep 22, 2026
Rated: Buy
Price Target: $106
Current: $85.25
Upside: +24.34%
Sep 17, 2026
Reiterated: Buy
Price Target: $114
Current: $99.94
Upside: +14.07%
Sep 15, 2026
Reiterated: Buy
Price Target: $69
Current: $25.13
Upside: +174.57%
Sep 2, 2026
Reiterated: Buy
Price Target: $45 → $64
Current: $55.39
Upside: +15.54%
Aug 25, 2026
Rated: Buy
Price Target: $159 → $170
Current: $161.58
Upside: +5.21%
Aug 18, 2026
Reiterated: Buy
Price Target: $9
Current: $1.97
Upside: +356.85%
Aug 17, 2026
Initiated Coverage: Buy
Price Target: $58
Current: $45.55
Upside: +27.33%
Aug 7, 2026
Reiterated: Buy
Price Target: $44
Current: $18.16
Upside: +142.29%
Aug 7, 2026
Rated: Buy
Price Target: $165 → $187
Current: $172.52
Upside: +8.39%
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $14.27
Upside: -
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $255.76
Upside: -
Aug 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $12.42
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: $30 → $35
Current: $31.74
Upside: +10.27%
Aug 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $101.10
Upside: -
Feb 25, 2026
Reiterated: Hold
Price Target: n/a
Current: $319.12
Upside: -
Apr 5, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.02
Upside: n/a
May 5, 2021
Reiterated: Buy
Price Target: $65 → $82
Current: $66.89
Upside: n/a
Mar 18, 2020
Reiterated: Buy
Price Target: $27
Current: $23.73
Upside: n/a
Dec 6, 2018
Rated: Hold
Price Target: n/a
Current: $3.05
Upside: n/a
Nov 11, 2016
Reiterated: Buy
Price Target: n/a
Current: $1.10
Upside: n/a
Nov 6, 2015
Reiterated: Buy
Price Target: $1
Current: $13.17
Upside: n/a
Apr 19, 2013
Reiterated: Buy
Price Target: $636
Current: $399.05
Upside: n/a
Apr 9, 2013
Upgraded: Buy
Price Target: $15 → $14
Current: $6.08
Upside: n/a
Apr 17, 2009
Downgraded: Sell
Price Target: n/a
Current: $6.07
Upside: n/a